313
Views
10
CrossRef citations to date
0
Altmetric
Oncology

Quality of life in treatment of AK: Treatment burden of ingenol mebutate gel is small and short lasting

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Eggert Stockfleth & Mike Bastian. (2018) Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis. Expert Opinion on Drug Metabolism & Toxicology 14:9, pages 911-918.
Read now
Hanna Norrlid, Jenny M. Norlin, Heidi Holmstrup, Irena Malmberg, Karin Sartorius, Henrik Thormann, Gregor B. E. Jemec & Gunnel Ragnarson Tennvall. (2018) Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients. Journal of Dermatological Treatment 29:1, pages 68-73.
Read now
Marc Bourcier, Linda Stein Gold, Lyn Guenther, Camilla M Andreassen, Johan Selmer & Gary Goldenberg. (2017) A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm2 on the chest. Journal of Dermatological Treatment 28:7, pages 652-658.
Read now

Articles from other publishers (7)

C. So, A. E. Cust, L. G. Gordon, R. L. Morton, K. Canfell, P. Ngo, M. Dieng, K. McLoughlin & C. Watts. (2021) Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review. Skin Health and Disease 1:3.
Crossref
Alise Balcere, Māra Rone Kupfere, Ingrīda Čēma & Angelika Krūmiņa. (2019) Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp. Medicina 55:4, pages 92.
Crossref
Eleni Anthony, Karyn Lun & Saxon D. Smith. (2018) Full face ingenol mebutate for actinic keratosis: patient perspective. International Journal of Dermatology 58:1, pages e6-e9.
Crossref
E. Stockfleth, C.A. Harwood, C. Serra-Guillén, T. Larsson, M.L. Østerdal & T. Skov. (2018) Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp. British Journal of Dermatology 178:2, pages 433-442.
Crossref
Larissa S. Meier, Maria Schubert, Yasemin Göksu, Solveig Esmann, Gabrielle R. Vinding, Gregor B.E. Jemec & Günther F.L. Hofbauer. (2018) Swiss (German) Version of the Actinic Keratosis Quality of Life questionnaire. Dermatology 234:1-2, pages 51-59.
Crossref
Adem Sav, Asiyeh Salehi, Frances S. Mair & Sara S. McMillan. (2017) Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature. BMC Medical Research Methodology 17:1.
Crossref
G. Goldenberg. (2017) Treatment considerations in actinic keratosis. Journal of the European Academy of Dermatology and Venereology 31, pages 12-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.